Ben Fidler will be returning back to the biotech world as he joins the team at BioPharma Dive as a senior editor.
Previously, he was a deputy editor biotech at Xconomy where he managed a team of biotech writers for a digital media and events company, reporting directly to the editor-in-chief.
He also covered the global biotech and pharmaceutical industry, focusing on breaking news and unique angles.
He also served as a senior reporter, bankruptcy and restructuring and senior reporter, health care at The Deal LLC. There, he covered multi-billion-dollar M&A transactions, venture financings, high-profile restructurings and much more.
Fidler received his bachelor’s degree in English and journalism from Binghamton University.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…